Ototoxicity of cis-diamminedichloroplatinum (II): Influence of dose, schedule and mode of administration
- 1 January 1983
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 19 (1) , 53-58
- https://doi.org/10.1016/0277-5379(83)90398-x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Auditory toxicity effects of long‐term cis‐dichlorodiammineplatinum II therapy in genitourinary cancer patientsJournal of Surgical Oncology, 1981
- E.O.R.T.C. phase II study of cisplatin in cyvadic-resistant soft tissue sarcomaPublished by Elsevier ,1979
- Chemotherapy for advanced and recurrent squamous cell carcinoma of the head and neck with high and low dose cis-diamminedichloroplatinumThe American Journal of Surgery, 1978
- cis-Platinum OtotoxicityClinical Toxicology, 1978
- Pharmacokinetical, histological, and histochemical investigations on the ototoxicity of gentamicin, tobramycin, and amikacinEuropean Archives of Oto-Rhino-Laryngology, 1977
- PHASE-2 STUDY OF CIS-DICHLORODIAMMINEPLATINUM(II) (NSC-119875) IN ADVANCED ADENOCARCINOMA OF OVARY1976
- CIS-DICHLORODIAMMINEPLATINUM(II) IN ADVANCED BLADDER CANCER1976
- Diamminodichloroplatinum in the Chemotherapy of Testicular TumorsJournal of Urology, 1974
- Guinea-Pig Hair Cell Pathology from Ototoxic AntibioticsActa Oto-Laryngologica, 1974
- Inner ear concentrations and ototoxicity of different antibiotics in local and systemic applicationInternational Journal of Audiology, 1973